Table 6 Pathway analysis through KEGG20,21,22 and WikiPathways databases. A: Short-term. B: Medium-term. C: Long-term.

From: The differential expression of adipose tissue genes in short, medium and long-term periods after bariatric surgery

 

Category

ID

Description

Strength

False discovery rate

A

KEGG

hsa05219

Bladder cancer

1.25

0.00011

A

KEGG

hsa05216

Thyroid cancer

1.22

0.00045

A

KEGG

hsa01040

Biosynthesis of unsaturated fatty acids

1.14

0.0134

A

KEGG

hsa04115

p53 signaling pathway

1.13

2.74E-05

A

KEGG

hsa04657

IL-17 signaling pathway

1.12

1.97E-06

A

WikiPathways

WP3299

let-7 inhibition of ES cell reprogramming

1.78

0.0011

A

WikiPathways

WP688

Catalytic cycle of mammalian flavin-containing monooxygenases (FMOs)

1.68

0.0131

A

WikiPathways

WP3601

Lipid particles composition

1.6

0.0023

A

WikiPathways

WP4586

Metabolism of alpha-linolenic acid

1.6

0.016

A

WikiPathways

WP4211

Transcriptional cascade regulating adipogenesis

1.45

0.005

B

KEGG

hsa05150

Staphylococcus aureus infection

1.45

2.77E-07

B

KEGG

hsa05140

Leishmaniasis

1.33

0.00028

B

KEGG

hsa05144

Malaria

1.29

0.0129

B

KEGG

hsa04145

Phagosome

1.28

2.77E-07

B

KEGG

hsa04610

Complement and coagulation cascades

1.26

0.00049

B

WikiPathways

WP3937

Microglia pathogen phagocytosis pathway

1.84

2.76E-11

B

WikiPathways

WP4146

Macrophage markers

1.83

0.0247

B

WikiPathways

WP3678

Amplification and expansion of oncogenic pathways as metastatic traits

1.73

0.0027

B

WikiPathways

WP2007

Iron metabolism in placenta

1.7

0.0361

B

WikiPathways

WP4724

Omega-9 fatty acid synthesis

1.63

0.0406

C

KEGG

hsa05150

Staphylococcus aureus infection

1.49

1.25E-07

C

KEGG

hsa05140

Leishmaniasis

1.37

0.00017

C

KEGG

hsa05144

Malaria

1.34

0.0103

C

KEGG

hsa01523

Antifolate resistance

1.33

0.0495

C

KEGG

hsa04145

Phagosome

1.32

1.25E-07

C

WikiPathways

WP3937

Microglia pathogen phagocytosis pathway

1.88

1.10E-11

C

WikiPathways

WP4146

Macrophage markers

1.87

0.0204

C

WikiPathways

WP3678

Amplification and expansion of oncogenic pathways as metastatic traits

1.77

0.0021

C

WikiPathways

WP4891

COVID-19 adverse outcome pathway

1.65

0.0419

C

WikiPathways

WP4136

Fibrin complement receptor 3 signaling pathway

1.61

5.82E-05

Back to article page